Lv21
130 积分 2025-10-11 加入
Efficacy and safety of Omalizumab in the treatment of CSU: a meta-analysis of a randomized controlled trial
33分钟前
已完结
721 - Efficacy and safety of povorcitinib for extensive vitiligo: 52-week results from a double-blinded, placebo-controlled, dose-ranging phase 2b study
4天前
已完结
The efficacy of topical 0.025% capsaicin gel for the treatment of lichen amyloidosis: A pilot study
7天前
已关闭
Tofacitinib for the Treatment of Primary Localized Cutaneous Amyloidosis
7天前
已完结
Non-Invasive Tests: Establishing efficacy for metabolic dysfunction associated steatohepatitis beyond the biopsy—current perspectives from the division of hepatology and nutrition, US Food and Drug Administration
11天前
已完结
Oral tofacitinib in comparison with dexamethasone oral mini-pulse therapy for the treatment of active nonsegmental vitiligo: A randomized controlled trial
20天前
已完结
Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL‐17A Inhibitors: A Population‐Based Study
20天前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
25天前
已完结
Treatment of chronic plaque psoriasis: An overview on current update
1个月前
已完结
Safety, tolerability, pharmacokinetics and efficacy of HB0017, a humanized monoclonal antibody that targets interleukin-17A, in healthy participants and patients with moderate-to-severe plaque psoriasis
1个月前
已完结
皖公网安备34019202002308
